The rising prevalence in GLP-1 agonists for diabetes has sparked a debate about formats: transdermal systems versus capsules. Traditionally , GLP-1 drugs were exclusively available in oral form, but the https://rebeccajinu878656.blogsumer.com/39873176/glp-1-skin-applications-vs-pills-which-suitable-for-individuals